The review focuses explicitly on Glucagon-Like Peptide-1 (GLP-1) receptor agonists, newer multi-receptor agonists, and emerging oral small-molecule therapies
Liver Patients with liver diseases should exercise caution when taking HAVGLO INJECTION 1 as it may alter liver function tests
Participants randomized to retatrutide initiated treatment with 2 mg once weekly and increased the dose in a stepwise approach every four weeks until reaching the target dose of 9 mg (via steps at 2 mg, 4 mg, and 6 mg) or 12 mg (via steps at 2 mg, 4 mg, 6 mg, and 9 mg)
Whilst there is no official contraindication preventing their concurrent use, the evidence supporting additional benefits from this combination remains limited
Incretins are gut hormone signals that help coordinate appetite, digestion, insulin release, and blood glucose handling after meals
Husain M et al